In Vitro & In Vivo Diagnostic Substances
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 81.3K | -- | 2.75% | -- | 2026-03-31 |
| HRT FINANCIAL LP | 62.5K | -- | 2.11% | -- | 2026-03-31 |
| BlackRock, Inc. | 34.7K | -- | 1.17% | -859 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 32.2K | -- | 1.09% | +17.0K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 20.2K | -- | 0.68% | -- | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 15.3K | -- | 0.52% | -- | 2026-03-31 |
| Scientech Research LLC | 13.9K | -- | 0.47% | -- | 2026-03-31 |
| UBS Group AG | 9.9K | -- | 0.34% | +9.0K | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 4.0K | -- | 0.13% | -- | 2026-03-31 |
| Tower Research Capital LLC (TRC) | 2.2K | -- | 0.07% | +1.4K | 2026-03-31 |
